-
-
-
-
-
-
-
UPDATE: H.C. Wainwright Downgrades Meridian Biosciences (VIVO) to Neutral
-
-
-
-
-
-
-
Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities
-
-
-
-
-
-
-
Meridian Closes Acquisition of BreathTek® Business
-
-
-
-
-
-
-
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021
-
-
-
-
-
-
-
Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
-
-
-
-
-
-
-
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
-
-
-
-
-
-
-
Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

